These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33477443)

  • 21. A randomized, placebo-controlled, crossover study of an herbal preparation containing Vernonia cinerea in the treatment of type 2 diabetes.
    Bin Sayeed MS; Mostofa AG; Ferdous FM; Islam MS
    J Altern Complement Med; 2013 Sep; 19(9):767-71. PubMed ID: 23581458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
    Oh MR; Park SH; Kim SY; Back HI; Kim MG; Jeon JY; Ha KC; Na WT; Cha YS; Park BH; Park TS; Chae SW
    BMC Complement Altern Med; 2014 Jul; 14():237. PubMed ID: 25015735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromocriptine: a novel approach to the treatment of type 2 diabetes.
    Pijl H; Ohashi S; Matsuda M; Miyazaki Y; Mahankali A; Kumar V; Pipek R; Iozzo P; Lancaster JL; Cincotta AH; DeFronzo RA
    Diabetes Care; 2000 Aug; 23(8):1154-61. PubMed ID: 10937514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
    Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
    Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial.
    Yen CH; Chu YJ; Lee BJ; Lin YC; Lin PT
    Br J Nutr; 2018 Jul; 120(1):57-63. PubMed ID: 29936921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance.
    Garcia AL; Otto B; Reich SC; Weickert MO; Steiniger J; Machowetz A; Rudovich NN; Möhlig M; Katz N; Speth M; Meuser F; Doerfer J; Zunft HJ; Pfeiffer AH; Koebnick C
    Eur J Clin Nutr; 2007 Mar; 61(3):334-41. PubMed ID: 16988651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginseng and ginsenoside Re do not improve β-cell function or insulin sensitivity in overweight and obese subjects with impaired glucose tolerance or diabetes.
    Reeds DN; Patterson BW; Okunade A; Holloszy JO; Polonsky KS; Klein S
    Diabetes Care; 2011 May; 34(5):1071-6. PubMed ID: 21411505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination insulin/glyburide therapy in type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation.
    Falko JM; Osei K
    Am J Med; 1985 Sep; 79(3B):92-101. PubMed ID: 3931467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Vuksan V; Sung MK; Sievenpiper JL; Stavro PM; Jenkins AL; Di Buono M; Lee KS; Leiter LA; Nam KY; Arnason JT; Choi M; Naeem A
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):46-56. PubMed ID: 16860976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and safety of concentrated herbal extract granules, YH1, as an add-on medication in poorly controlled type 2 diabetes: A randomized, double-blind, placebo-controlled pilot trial.
    Huang YH; Chen ST; Liu FH; Hsieh SH; Lin CH; Liou MJ; Wang CC; Huang CH; Liu GH; Lin JR; Yang LY; Hsu TY; Lee MC; Huang CT; Wu YH
    PLoS One; 2019; 14(8):e0221199. PubMed ID: 31415655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Korean red ginseng improves glucose control in subjects with impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus.
    Bang H; Kwak JH; Ahn HY; Shin DY; Lee JH
    J Med Food; 2014 Jan; 17(1):128-34. PubMed ID: 24456363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men.
    Kabir M; Oppert JM; Vidal H; Bruzzo F; Fiquet C; Wursch P; Slama G; Rizkalla SW
    Metabolism; 2002 Jul; 51(7):819-26. PubMed ID: 12077724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
    Khalili N; Fereydoonzadeh R; Mohtashami R; Mehrzadi S; Heydari M; Huseini HF
    J Evid Based Complementary Altern Med; 2017 Oct; 22(4):603-608. PubMed ID: 29228792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
    Fritsche A; Schmülling RM; Häring HU; Stumvoll M
    Acta Diabetol; 2000 Mar; 37(1):13-8. PubMed ID: 10928231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.
    Simonson DC; Kourides IA; Feinglos M; Shamoon H; Fischette CT
    Diabetes Care; 1997 Apr; 20(4):597-606. PubMed ID: 9096986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of zinc supplementation on superoxide dismutase activity and gene expression, and metabolic parameters in overweight type 2 diabetes patients: A randomized, double-blind, controlled trial.
    Nazem MR; Asadi M; Jabbari N; Allameh A
    Clin Biochem; 2019 Jul; 69():15-20. PubMed ID: 31129183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes.
    Kelley DE; Bidot P; Freedman Z; Haag B; Podlecki D; Rendell M; Schimel D; Weiss S; Taylor T; Krol A; Magner J
    Diabetes Care; 1998 Dec; 21(12):2056-61. PubMed ID: 9839094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of the dietary supplement DBCare® in patients with type 2 diabetes mellitus and inadequate glycemic control.
    Rotman-Pikielny P; Ness-Abramof R; Charach G; Roitman A; Zissin R; Levy Y
    J Am Coll Nutr; 2014; 33(1):55-62. PubMed ID: 24533608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Fenugreek Seeds on Serum Metabolic Factors and Adiponectin Levels in Type 2 Diabetic Patients.
    Rafraf M; Malekiyan M; Asghari-Jafarabadi M; Aliasgarzadeh A
    Int J Vitam Nutr Res; 2014; 84(3-4):196-205. PubMed ID: 26098483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.